Artrya Salix for Administrators

An enterprise solution that improves the diagnostic investigation of stable and acute chest pain patients

Keep pace with growing CCTA demand without adding staff

Identify patients who truly require life-saving care

Free up beds for high-risk patients

Optimize use of capital equipment and return on investment

Major predictors of heart attack are overlooked during patient evaluations

Traditional methods of CCTA analysis preclude reporting the specific types of plaque indicative of adverse cardiac events when evaluating coronary disease. Substantial manual workup time, physician team disagreement and lack of standardization create a disjointed system. These factors often lead to inefficient diagnostic testing and poor patient outcomes.

Artrya Salix streamlines the diagnosis of chest pain for effective patient management

Artrya Salix delivers a new approach for collaborative diagnosis. From an easy-to-use web application, physicians can rapidly read and report CCTA scan interpretations that include important plaque features associated with heart attack risk.

 
 

Reduce unnecessary healthcare costs by including AI in the analysis of CCTA scans.

Reduce unnecessary healthcare costs by including AI in the analysis of CCTA scans.

Minimal investment

No capital equipment investment required

Simple deployment

No downloads. No installation. No hardware

Intuitive interface

Minimal user training required

Compatible

Suitable for use with leading brands of CCTA scanners